Jazz Pharmaceuticals plc
Hedge Funds Holdings
Last updated:
Jazz Pharmaceuticals plc‘s stocks are currently a part of 326 hedge funds’ portfolios, which represents 58.89% of the total amount of its stocks outstanding. This makes up a total of 37.04M shares of Jazz Pharmaceuticals plc. Compared to the previous quarter, the number fell by -34.54% or -19.54M shares fewer. As for the holding position changes, 28.83% (94) of current hedge fund investors increased the number of shares held, 37.42% (122) of current holders sold a part of the shares held, and 8.59% (28) closed the holdings completely. 38 hedge funds are new holders of Jazz Pharmaceuticals plc stock in Q2 2022, it is 11.66% of total holders.
Hedge funds holding Jazz Pharmaceuticals (Q3 2017 – Q2 2022)
| Q3 2017 | 302 |
|---|---|
| Q4 2017 | 324 |
| Q1 2018 | 320 |
| Q2 2018 | 372 |
| Q3 2018 | 396 |
| Q4 2018 | 409 |
| Q1 2019 | 415 |
| Q2 2019 | 412 |
| Q3 2019 | 398 |
| Q4 2019 | 436 |
| Q1 2020 | 396 |
| Q2 2020 | 375 |
| Q3 2020 | 381 |
| Q4 2020 | 428 |
| Q1 2021 | 432 |
| Q2 2021 | 487 |
| Q3 2021 | 432 |
| Q4 2021 | 436 |
| Q1 2022 | 438 |
| Q2 2022 | 326 |
Hedge funds changes in Jazz Pharmaceuticals positions (Q3 2017 – Q2 2022)
| Q3 2017 | 34 | 117 | 102 | 45 | 4 |
|---|---|---|---|---|---|
| Q4 2017 | 67 | 101 | 104 | 41 | 11 |
| Q1 2018 | 45 | 108 | 116 | 43 | 8 |
| Q2 2018 | 92 | 118 | 104 | 36 | 22 |
| Q3 2018 | 68 | 144 | 123 | 44 | 17 |
| Q4 2018 | 80 | 155 | 124 | 64 | -14 |
| Q1 2019 | 68 | 186 | 114 | 60 | -13 |
| Q2 2019 | 59 | 154 | 145 | 58 | -4 |
| Q3 2019 | 43 | 161 | 135 | 57 | 2 |
| Q4 2019 | 85 | 162 | 132 | 34 | 23 |
| Q1 2020 | 49 | 124 | 166 | 84 | -27 |
| Q2 2020 | 49 | 134 | 143 | 67 | -18 |
| Q3 2020 | 67 | 116 | 152 | 58 | -12 |
| Q4 2020 | 80 | 130 | 169 | 32 | 17 |
| Q1 2021 | 58 | 146 | 168 | 51 | 9 |
| Q2 2021 | 101 | 212 | 126 | 45 | 3 |
| Q3 2021 | 49 | 140 | 168 | 101 | -26 |
| Q4 2021 | 69 | 136 | 162 | 63 | 6 |
| Q1 2022 | 71 | 144 | 145 | 57 | 21 |
| Q2 2022 | 38 | 94 | 122 | 28 | 44 |
Hedge funds changes in Jazz Pharmaceuticals stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 38,162,000 | 66,789,000 |
|---|---|---|
| Q4 2017 | 16,811,000 | 39,000,045,174,000 |
| Q1 2018 | 31,676,000 | 27,178,000 |
| Q2 2018 | 117,206,000 | 40,724,850 |
| Q3 2018 | 29,508,000 | 63,615,000 |
| Q4 2018 | 18,046,000 | 25,258,000 |
| Q1 2019 | 26,460,000 | 32,550,000 |
| Q2 2019 | 29,967,000 | 20,325,000 |
| Q3 2019 | 35,495,000 | 23,969,000 |
| Q4 2019 | 33,860,000 | 34,769,520 |
| Q1 2020 | 18,278,000 | 26,508,000 |
| Q2 2020 | 22,411,000 | 46,915,860 |
| Q3 2020 | 112,463,000 | 68,454,000 |
| Q4 2020 | 114,863,000 | 37,548,500 |
| Q1 2021 | 270,208,000 | 100,402,550 |
| Q2 2021 | 225,126,000 | 137,156,400 |
| Q3 2021 | 66,533,000 | 73,435,300 |
| Q4 2021 | 34,163,000 | 65,430,480 |
| Q1 2022 | 58,679,000 | 30,156,000 |
| Q2 2022 | 5,944,000 | 15,101,200 |